Close
Back to CRVS Stock Lookup

Corvus Pharma (CRVS) – Hot FDA News

Jul 15, 2021 04:06 PM Corvus Pharma (CRVS) Discontinues Phase 3 Study of Mupadolimab for COVID-19 Due to Vaccine Effectiveness in Reducing Hospitalizations
Nov 13, 2017 05:47 AM Corvus Pharma (CRVS) Reports Updated Clinical Data from Phase 1/1b Study of CPI-444 and Biomarker Data for Potential Use in Patient Selection
Jun 5, 2017 08:32 AM

Back to CRVS Stock Lookup